A Game-Changer for Diabetes: Polymer Delivers Insulin Painlessly Through Skin
November 25, 2025
Brand Name :
alinia
Synonyms :
Nitazoxanide, Nitazoxanida
Class :
Anti-parasitic
Dosage Forms & StrengthsÂ
TabletÂ
500mgÂ
Oral suspensionÂ
100mg/5mlÂ
500
mg
Tablet
Orally 
every 12 hrs
3
days
Dosage Forms & StrengthsÂ
TabletÂ
500mgÂ
Oral suspensionÂ
100mg/5mlÂ
<1 year: Safety and efficacy not established
1-3 years:5 ml orally every 12 hours for three days
4-11 years: 10 ml orally every 12 hours for three days
>12 years: 500mg orally every 12 hours for three days
It may enhance the immunosuppressive effects when combined with idecabtagene vicleucel
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
Frequency defined:Â Â
1-10%Â
Abdominal painÂ
NauseaÂ
VomitingÂ
HeadacheÂ
DiarrheaÂ
ChromaturiaÂ
<1%Â
AnorexiaÂ
Increased levels of creatinineÂ
DizzinessÂ
FeverÂ
InfectionÂ
PruritisÂ
Enlarged salivary glandsÂ
Increased ALTÂ
Increased appetiteÂ
DiaphoresisÂ
Eye discolorationÂ
FlatulenceÂ
Thinitis Â
Post-marketing reportsÂ
DizzinessÂ
RashÂ
DiarrheaÂ
dyspneaÂ
Pregnancy consideration: Insufficient data availableÂ
Lactation: Excretion of the drug in human breast milk is unknownÂ
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Patient information leafletÂ
Generic Name: nitazoxanideÂ
Pronounced:  [ NYE-ta-ZOX-a-nide ]Â
Why do we use nitazoxanide?Â
It is used to treat diarrhea caused by giardia